Try a new search

Format these results:

Searched for:

in-biosketch:true

person:frencj02

Total Results:

563


Antiepileptic drug interactions

French, J A; Gidal, B E
This article reviews the potential interactions of antiepileptic drugs (AEDs) and the pharmacokinetic and pharmacodynamic principles involved. It describes the absorptive and distributive properties of AEDs and the effects on protein binding, hepatic metabolism, and elimination resulting from co-administration of AEDs with food or other drugs. Drug behavior is a function of absorption, metabolism, distribution, and elimination. Administration of either multiple AEDs or a combination of AEDs plus drugs for other conditions can modify any of these physiologic processes, possibly resulting in complex interactions. These may include alterations in the bio-availability and absorption of a drug and changes in half-life and serum level through induction or inhibition of hepatic metabolism. In most cases, increases or decreases in serum concentrations will signal a drug interaction. In other cases, clinically significant drug interactions remain undetected owing to apparently stable serum concentrations. Co-administration of drugs may affect the rate of clearance of one or both drugs. The effect on clearance varies, owing to genetic factors, patient characteristics (age and presence of co-morbidities), and individual responses. AEDs that induce hepatic metabolism can also influence the metabolism of concomitantly administered non-epilepsy medications and can interfere with oral contraceptives, as well as vitamins D and K. Patients with renal insufficiency or advanced age may experience incomplete renal excretion and should receive reduced dosages of drug. Understanding the pharmacokinetics and pharmacodynamic properties of AEDs and the route of metabolism of all competing drugs is important for optimal management of patients with epilepsy and for prevention of avoidable drug interactions
PMID: 11092610
ISSN: 0013-9580
CID: 102121

Can we approve new drugs for use in monotherapy

French JA; Delanty N
ORIGINAL:0006642
ISSN: n/a
CID: 102394

Therapeutic monitoring of antiepileptic drugs : efficacy, safety and drug interactions

French JA; Wilder BJ
[S.l. : s.n.], 2000
Extent: S1 - S47
ISBN: n/a
CID: 1903

Infections rates among patients participating in clinical trials

Ting, Tricia Y.; French, Jacqueline A.; Cramer, Joyce
BIOSIS:PREV200100116434
ISSN: 0013-9580
CID: 102334

Use of oxcarbazepine in clinical practice: Data from the PADS group

Harden, Cynthia L.; French, Jacqueline A.; Fix, Aaron F.; Jacobson, Mercedes; Rosenfeld, William; Montouris, Georgia D.; Tatum, William O.; Nikolov, Blagovest G.; Burgerman, Robert
BIOSIS:PREV200100136252
ISSN: 0013-9580
CID: 102376

Dose-response trial of pregabalin add-on therapy in patients with partial seizures

French, Jacqueline A.; Malicsi, Michael J. R.; Kugler, Alan R.; Knapp, Lloyd E.; Laughlin, Kathryn A.; Bockbrader, Howard N.; Romine, Susan K.; Robbins, Jeffery L.; Garofalo, Elizabeth A.
BIOSIS:PREV200100122217
ISSN: 0013-9580
CID: 102372

Differential diagnosis of epileptic and non-epileptic seizures, 2000

Chapter by: French JA
in: Penn neurology 2000 : management of common neurologic problems by Stern MB [Eds]
Irvington NY : AlphaMedica Press, 2000
pp. -
ISBN: n/a
CID: 5175

Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy

Kerrigan, John F.; Fisher, Robert S.; Blum, David E.; Shetter, Andrew; Krone, Selma; Litt, Brian; French, Jacqueline A.; Dichter, Marc; Baltuch, Gordon; Brodie, Mary Ann; Rise, Mark; Graves, Nina
BIOSIS:PREV200100118265
ISSN: 0013-9580
CID: 102383

Rapid onset of action of Levetiracetam in refractory epileptic patients [Meeting Abstract]

French, JA; Privitera, M; Arrigo, C; Verdru, P
ISI:000086557800221
ISSN: 0028-3878
CID: 2338222

Functional MRI and the Wada test provide complementary information for predicting post-operative seizure control

Killgore, W D; Glosser, G; Casasanto, D J; French, J A; Alsop, D C; Detre, J A
Prediction of post-surgical seizure relief and potential cognitive deficits secondary to anterior temporal lobectomy (ATL) are important to pre-surgical planning. Although the intracarotid amobarbital test (IAT) is predictive of post-ATL seizure outcome, development of non-invasive and more precise means for determining post-ATL seizure relief are needed. We previously reported on a technique utilizing functional MRI (fMRI) to evaluate the relative functional adequacy of mesial temporal lobe structures in preparation for ATL. In the present study, we report follow-up outcome data on eight temporal lobe epilepsy (TLE) patients 1-year post-ATL who were evaluated pre-surgically using IAT and fMRI. Functional memory lateralization using fMRI predicted post-ATL seizure outcome as effectively as the IAT. In general, asymmetry of functional mTL activation favouring the non-epileptic hemisphere was associated with seizure-free status at 1-year follow-up. Moreover, when combined, fMRI and IAT provided complementary data that resulted in improved prediction of post-operative seizure control compared with either procedure alone
PMID: 10627406
ISSN: 1059-1311
CID: 102102